药学与临床研究2024,Vol.32Issue(1) :85-89.

药品第二医药用途专利的审查

Examination of Patent for Second Medical Use of Drugs

赵建民 梁媛
药学与临床研究2024,Vol.32Issue(1) :85-89.

药品第二医药用途专利的审查

Examination of Patent for Second Medical Use of Drugs

赵建民 1梁媛2
扫码查看

作者信息

  • 1. 国家知识产权局专利局专利审查协作天津中心,天津 300304
  • 2. 天津市第一中心医院,天津 300192
  • 折叠

摘要

目的:为改进我国药品第二医药用途发明的审查给出建议.方法:回溯瑞士型权利要求在欧洲的起源、发展和终结,探讨瑞士型权利要求的本质,从审查理论和我国制药工业发展、临床应用的现实角度对瑞士型权利要求的给药特征进行分析.结果:对第二医药用途发明的给药特征进行保护是世界发展趋势,改进给药特征的创造性劳动应予以保护.结论:建议加大我国瑞士型权利要求的保护强度,激励我国医药工业的发展.

Abstract

Objective:To provide suggestions for improving the examination of second medical use in-ventions of drugs in China.Method:Tracing back the origin,development,and termination of Swiss type claims in Europe,exploring the essence of Swiss type claims,and analyzing the drug administration char-acteristics of Swiss type claims from the perspectives of review theory,China's pharmaceutical industry de-velopment and clinical reality.Results:The protection of the drug delivery characteristics of the invention for the second medical use is a global development trend,and creative labor to improve drug delivery characteristics should be protected.Conclusion:In order to stimulate the development of China's pharma-ceutical industry,it is recommended to strengthen the protection of Swiss-type claims in China.

关键词

瑞士型权利要求/给药特征/可专利性/仿制药

Key words

Swiss-type claim/Administration characteristics/Patentability/Generics

引用本文复制引用

出版年

2024
药学与临床研究
江苏省药学会

药学与临床研究

CSTPCD
影响因子:0.95
ISSN:1673-7806
参考文献量5
段落导航相关论文